TABLE 5

Effect on Medical Adherence Report Scale (MARS)^#, difference in participants' forgetfulness to take their asthma medication, within and between treatment with AsthmaTuner or conventional treatment in all study participants, and stratified by cohorts in primary care, paediatric specialist care and at least weekly average use of AsthmaTuner

	Subjects	MARS difference: AsthmaTuner	MARS difference: conventional treatment	Mean MARS difference: *AsthmaTuner versus* conventional treatment**	Difference in crossover effect
All participants	77	0.06 (−0.11–0.24); p=0.47	−0.06 (−0.23–0.10); p=0.43	0.13 (−0.11–0.38); p=0.29	p=0.64
Primary care	37	0.11 (−0.14–0.35); p=0.38	−0.14 (−0.35–0.08); p=0.20	0.23 (−0.11–0.57); p=0.17	p=0.39
Paediatric specialist care	40	0.03 (−0.24–0.29); p=0.85	0.00 (−0.25–0.25); p=1.00	0.08 (−0.29–0.45); p=0.67	p=0.87
AsthmaTuner used on average once weekly or more
Primary and paediatric cohort	62	0.19 (0.01–0.38); p=0.04	−0.08 (−0.27–0.11); p=0.40	0.27 (0.00–0.55); p=0.05	p=0.37
Primary care	27	0.26 (0.02–0.49); p=0.03	−0.19 (−0.43–0.06); p=0.13	0.45 (0.13–0.77); p=0.01	p=0.40
Paediatric care	35	0.14 (−0.14–0.42); p=0.30	0.00 (−0.29–0.29); p=1.00	0.16 (−0.26–0.57); p=0.45	p=0.65

Data are presented as mean (95% CI), unless otherwise stated. ^#: MARS (how often respondents forgot to take asthma medications): 1=always, 2=often, 3=sometimes, 4=rarely, 5=never.